Effect of cocaine on Fas-associated protein with death domain in the rat brain: Individual differences in a model of differential vulnerability to drug abuse

Neuropsychopharmacology

Volumn 34, Issue 5, 2009, Pages 1123-1134

  García Fuster, María Julia ^a   Clinton, Sarah M ^a   Watson, Stanley J ^a   Akil, Huda ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Apoptosis; Cocaine; FADD; HR LR phenotype; Proliferation; Rat brain

Indexed keywords

COCAINE; DOPAMINE 2 RECEPTOR; FAS ASSOCIATED DEATH DOMAIN PROTEIN; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN; BREEDING; CELL MEMBRANE; CELL NUCLEUS; COCAINE DEPENDENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSOL; DRUG ABUSE; DRUG WITHDRAWAL; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSITIZATION; SIGNAL TRANSDUCTION; SUBSTANCE ABUSE;

ANIMALS; APOPTOSIS; BEHAVIOR, ADDICTIVE; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; COCAINE-RELATED DISORDERS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; MALE; PHENOTYPE; POLY(ADP-RIBOSE) POLYMERASES; RATS; RATS, INBRED STRAINS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RNA, MESSENGER; SUBSTANCE-RELATED DISORDERS;

EID: 62349090510     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2008.88     Document Type: Article

References (76)

1. Abdolzade-Bavil A, Hayes S, Goretzki L, Kroger M, Anders J, Hendriks R (2004). Convenient and versatile subcellular extraction procedure, that facilitates classical protein expression profiling and functional protein analysis. Proteomics 4: 1397-1405.
2. Alappat EC, Feig C, Boyerinas B, Volkland J, Samuels M, Murmann AE et al (2005). Phosphorylation of FADD at serine 194 by CKIalpha regulates its nonapoptotic activities. Mol Cell 19: 321-332.
3. Algeciras-Schimnich A, Shen L, Barnhart BC, Murmann AE, Burkhardt JK, Peter ME (2002). Molecular ordering of the initial signaling events of CD95. Mol Cell Biol 22: 207-220.
4. Ballaz SJ, Akil H, Watson SJ (2007a). Analysis of 5-HT6 and 5-HT7 receptor gene expression in rats showing differences in noveltyseeking behavior. Neuroscience 147: 428-438.
5. Ballaz SJ, Akil H, Watson SJ (2007b). The CCK-system mediates adaptation to novelty-induced stress in the rat: a pharmacological evidence. Neurosci Lett 428: 27-32.
6. Ballesteros-Yanez I, Valverde O, Ledent C, Maldonado R, DeFelipe J (2007). Chronic cocaine treatment alters dendritic arborization in the adult motor cortex through a CB1 cannabinoid receptor-dependent mechanism. Neuroscience 146: 1536-1545.
7. Barry U, Zuo Z (2005). Opioids: old drugs for potential new applications. Curr Pharm Des 11: 1343-1350.
8. Beisner DR, Chu IH, Arechiga AF, Hedrick SM, Walsh CM (2003). The requirements for Fas-associated death domain signaling in mature T cell activation and survival. J Immunol 171: 247-256.
9. Beitner-Johnson D, Nestler EJ (1991). Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. J Neurochem 57: 344-347.
10. Berke JD, Hyman SE (2000). Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25: 515-532.
11. Bhojani MS, Chen G, Ross BD, Beer DG, Rehemtulla A (2005). Nuclear localized phosphorylated FADD induces cell proliferation and is associated with aggressive lung cancer. Cell Cycle 4: 1478-1481.
12. Bi FF, Xiao B, Hu YQ, Tian FF, Wu ZG, Ding L et al (2008). Expression and localization of Fas-associated proteins following focal cerebral ischemia in rats. Brain Res 1191: 30-38.
13. Cagnol S, Van Obberghen-Schilling E, Chambard JC (2006). Prolonged activation of ERK1,2 induces FADD-independent caspase 8 activation and cell death. Apoptosis 11: 337-346.
14. Cameron HA, Hazel TG, McKay RD (1998). Regulation of neurogenesis by growth factors and neurotransmitters. J Neurobiol 36: 287-306.
15. Chefer VI, Zakharova I, Shippenberg TS (2003). Enhanced responsiveness to novelty and cocaine is associated with decreased basal dopamine uptake and release in the nucleus accumbens: quantitative microdialysis in rats under transient conditions. J Neurosci 23: 3076-3084.
16. Chen G, Bhojani MS, Heaford AC, Chang DC, Laxman B, Thomas DG et al (2005). Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas. Proc Natl Acad Sci USA 102: 12507-12512.
17. Cunha-Oliveira T, Rego AC, Cardoso SM, Borges F, Swerdlow RH, Macedo T et al (2006). Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine. Brain Res 1089: 44-54.
18. Desbarats J, Birge RB, Mimouni-Rongy M, Weinstein DE, Palerme JS, Newell MK (2003). Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat Cell Biol 5: 118-125.
19. Dey S, Snow DM (2007). Cocaine exposure in vitro induces apoptosis in fetal locus coeruleus neurons through TNF-alpha-mediated induction of Bax and phosphorylated c-Jun NH(2)-terminal kinase. J Neurochem 103: 542-556.
20. Di Chiara G, Imperato A (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85: 5274-5278.
21. Dietrich JB, Mangeol A, Revel MO, Burgun C, Aunis D, Zwiller J (2005). Acute or repeated cocaine administration generates reactive oxygen species and induces antioxidant enzyme activity in dopaminergic rat brain structures. Neuropharmacology 48: 965-974.
22. Dietz DM, Tapocik J, Gaval-Cruz M, Kabbaj M (2005). Dopamine transporter, but not tyrosine hydroxylase, may be implicated in determining individual differences in behavioral sensitization to amphetamine. Physiol Behav 86: 347-355.
23. Flagel SB, Clinton SM, Watson SJ, Robinson TE, Akil H (ed) (2007). Rats selectively bred on the basis of a novelty-seeking trait exhibit individual differences in the propensity to approach signals vs. goals: implications for addiction. Society for Neuroscience Annual Meeting. San Diego, CA: San Diego, CA.
24. Fumagalli F, Bedogni F, Maragnoli ME, Gennarelli M, Perez J, Racagni G et al (2003). Dopaminergic D2 receptor activation modulates FGF-2 gene expression in rat prefrontal cortex and hippocampus. J Neurosci Res 74: 74-80.
25. Fumagalli F, Pasquale L, Racagni G, Riva MA (2006). Dynamic regulation of fibroblast growth factor 2 (FGF-2) gene expression in the rat brain following single and repeated cocaine administration. J Neurochem 96: 996-1004.
26. Garcia-Fuster MJ, Ferrer-Alcon M, Miralles A, Garcia-Sevilla JA (2003). Modulation of Fas receptor proteins and dynamin during opiate addiction and induction of opiate withdrawal in rat brain. Naunyn Schmiedebergs Arch Pharmacol 368: 421-431.
27. Garcia-Fuster MJ, Miralles A, Garcia-Sevilla JA (2007). Effects of opiate drugs on Fas-associated protein with death domain (FADD) and effector caspases in the rat brain: regulation by the ERK1/2 MAP kinase pathway. Neuropsychopharmacology 32: 399-411.
28. Gomez-Angelats M, Cidlowski JA (2003). Molecular evidence for the nuclear localization of FADD. Cell Death Differ 10: 791-797.
29. Gosnell BA (2005). Sucrose intake enhances behavioral sensitization produced by cocaine. Brain Res 1031: 194-201.
30. Holmstrom TH, Schmitz I, Soderstrom TS, Poukkula M, Johnson VL, Chow SC et al (2000). MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly. EMBO J 19: 5418-5428.
31. Holmstrom TH, Tran SE, Johnson VL, Ahn NG, Chow SC, Eriksson JE (1999). Inhibition of mitogen-activated kinase signaling sensitizes HeLa cells to Fas receptor-mediated apoptosis. Mol Cell Biol 19: 5991-6002.
32. Hooks MS, Juncos JL, Justice Jr JB, Meiergerd SM, Povlock SL, Schenk JO et al (1994a). Individual locomotor response to novelty predicts selective alterations in D1 and D2 receptors and mRNAs. J Neurosci 14: 6144-6152.
33. Hooks MS, Sorg BA, Kalivas PW (1994b). The relationship between MRNA levels and the locomotor response to novelty. Brain Res 663: 312-316.
34. Hu S, Cheeran MC, Sheng WS, Ni HT, Lokensgard JR, Peterson PK (2006). Cocaine alters proliferation, migration, and differentiation of human fetal brain-derived neural precursor cells. J Pharmacol Exp Ther 318: 1280-1286.
35. Imam SZ, Duhart HM, Skinner JT, Ali SF (2005). Cocaine induces a differential dose-dependent alteration in the expression profile immediate early genes, transcription factors, and caspases in PC12 cells: a possible mechanism of neurotoxic damage in cocaine addiction. Ann NY Acad Sci 1053: 482-490.
36. Isgor C, Cecchi M, Kabbaj M, Akil H, Watson SJ (2003). Estrogen receptor beta in the paraventricular nucleus of hypothalamus regulates the neuroendocrine response to stress and is regulated by corticosterone. Neuroscience 121: 837-845.
37. Kabbaj M (2004). Neurobiological bases of individual differences in emotional and stress responsiveness: high responders-low responders model. Arch Neurol 61: 1009-1012.
38. Kabbaj M (2006). Individual differences in vulnerability to drug abuse: the high responders/low responders model. CNS Neurol Disord Drug Targets 5: 513-520.
39. Kabbaj M, Akil H (2001). Individual differences in novelty-seeking behavior in rats: a c-fos study. Neuroscience 106: 535-545.
40. Kabbaj M, Devine DP, Savage VR, Akil H (2000). Neurobiological correlates of individual differences in novelty-seeking behavior in the rat: differential expression of stress-related molecules. J Neurosci 20: 6983-6988.
41. Kalivas PW (2007). Neurobiology of cocaine addiction: implications for new pharmacotherapy. Am J Addict 16: 71-78.
42. Kalivas PW, Volkow ND (2005). The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162: 1403-1413.
43. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH et al (1995). Cytotoxicity-dependent APO-1 (Fas/ CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14: 5579-5588.
44. Kita JM, Parker LE, Phillips PE, Garris PA, Wightman RM (2007). Paradoxical modulation of short-term facilitation of dopamine release by dopamine autoreceptors. J Neurochem 102: 1115-1124.
45. Kreek MJ (1996). Cocaine, dopamine and the endogenous opioid system. J Addict Dis 15: 73-96.
46. Lee KH, Feig C, Tchikov V, Schickel R, Hallas C, Schutze S et al (2006). The role of receptor internalization in CD95 signaling. EMBO J 25: 1009-1023.
47. Luo Y, Kokkonen GC, Wang X, Neve KA, Roth GS (1998). D2 dopamine receptors stimulate mitogenesis through pertussis toxin-sensitive G proteins and Ras-involved ERK and SAP/JNK pathways in rat C6-D2L glioma cells. J Neurochem 71: 980-990.
48. Marinelli M, White FJ (2000). Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons. J Neurosci 20: 8876-8885.
49. Nassogne MC, Louahed J, Evrard P, Courtoy PJ (1997). Cocaine induces apoptosis in cortical neurons of fetal mice. J Neurochem 68: 2442-2450.
50. Nestler EJ (2001). Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2: 119-128.
51. Nestler EJ (2004). Molecular mechanisms of drug addiction. Neuropharmacology 47(Suppl 1): 24-32.
52. Nestler EJ (2005). Is there a common molecular pathway for addiction? Nat Neurosci 8: 1445-1449.
53. O'Reilly LA, Divisekera U, Newton K, Scalzo K, Kataoka T, Puthalakath H et al (2004). Modifications and intracellular trafficking of FADD/MORT1 and caspase-8 after stimulation of T lymphocytes. Cell Death Differ 11: 724-736.
54. Park HH, Lo YC, Lin SC, Wang L, Yang JK, Wu H (2007). The death domain superfamily in intracellular signaling of apoptosis and inflammation. Annu Rev Immunol 25: 561-586.
55. Park SM, Schickel R, Peter ME (2005). Nonapoptotic functions of FADD-binding death receptors and their signaling molecules. Curr Opin Cell Biol 17: 610-616.
56. Peter ME, Budd RC, Desbarats J, Hedrick SM, Hueber AO, Newell MK et al (2007). The CD95 receptor: apoptosis revisited. Cell 129: 447-450.
57. Piazza PV, Deminiere JM, Le Moal M, Simon H (1989). Factors that predict individual vulnerability to amphetamine self-administration. Science 245: 1511-1513.
58. Piazza PV, Le Moal ML (1996). Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu Rev Pharmacol Toxicol 36: 359-378.
59. Piazza PV, Rouge-Pont F, Deminiere JM, Kharoubi M, Le Moal M, Simon H (1991). Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration. Brain Res 567: 169-174.
60. Pierce RC, Kalivas PW (1997). A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 25: 192-216.
61. Pierre PJ, Vezina P (1997). Predisposition to self-administer amphetamine: the contribution of response to novelty and prior exposure to the drug. Psychopharmacology (Berl) 129: 277-284.
62. Robinson TE, Kolb B (2004). Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 47(Suppl 1): 33-46.
63. Roceri M, Molteni R, Fumagalli F, Racagni G, Gennarelli M, Corsini G et al (2001). Stimulatory role of dopamine on fibroblast growth factor-2 expression in rat striatum. J Neurochem 76: 990-997.
64. Screaton RA, Kiessling S, Sansom OJ, Millar CB, Maddison K, Bird A et al (2003). Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: a potential link between genome surveillance and apoptosis. Proc Natl Acad Sci USA 100: 5211-5216.
65. Sommer L, Rao M (2002). Neural stem cells and regulation of cell number. Prog Neurobiol 66: 1-18.
66. Stead JD, Clinton S, Neal C, Schneider J, Jama A, Miller S et al (2006). Selective breeding for divergence in novelty-seeking traits: heritability and enrichment in spontaneous anxiety-related behaviors. Behav Genet 36: 697-712.
67. Tegeder I, Geisslinger G (2004). Opioids as modulators of cell death and survival - unraveling mechanisms and revealing new indications. Pharmacol Rev 56: 351-369.
68. Wise RA, Bozarth MA (1985). Brain mechanisms of drug reward and euphoria. Psychiatr Med 3: 445-460.
69. Yamaguchi M, Suzuki T, Seki T, Namba T, Liu J, Arai H et al (2005). Decreased cell proliferation in the dentate gyrus of rats after repeated administration of cocaine. Synapse 58: 63-71.
70. Yan Z, Feng J, Fienberg AA, Greengard P (1999). D(2) dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons. Proc Natl Acad Sci USA 96: 11607-11612.
71. Yoo NJ, Lee SH, Jeong EG, Lee JW, Soung YH, Nam SW et al (2007). Expression of nuclear and cytoplasmic phosphorylated FADD in gastric cancers. Pathol Res Pract 203: 73-78.
72. Zhang GC, Mao LM, Liu XY, Parelkar NK, Arora A, Yang L et al (2007). In vivo regulation of Homer1a expression in the striatum by cocaine. Mol Pharmacol 71: 1148-1158.
73. Zhang J, Cado D, Chen A, Kabra NH, Winoto A (1998). Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 392: 296-300.
74. Zhang Y, Rosenberg S, Wang H, Imtiyaz HZ, Hou YJ, Zhang J (2005). Conditional Fas-associated death domain protein (FADD): GFP knockout mice reveal FADD is dispensable in thymic development but essential in peripheral T cell homeostasis. J Immunol 175: 3033-3044.
75. Zhu J, Bardo MT, Bruntz RC, Stairs DJ, Dwoskin LP (2007). Individual differences in response to novelty predict prefrontal cortex dopamine transporter function and cell surface expression. Eur J Neurosci 26: 717-728.
76. Zuliani C, Kleber S, Klussmann S, Wenger T, Kenzelmann M, Schreglmann N et al (2006). Control of neuronal branching by the death receptor CD95 (Fas/Apo-1). Cell Death Differ 13: 31-40.